Bloomage Biotechnology Corp Ltd (688363) - Total Liabilities

Latest as of March 2026: CN¥1.59 Billion CNY ≈ $232.72 Million USD

Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) has total liabilities worth CN¥1.59 Billion CNY (≈ $232.72 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bloomage Biotechnology Corp Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Bloomage Biotechnology Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688363 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Bloomage Biotechnology Corp Ltd Competitors by Total Liabilities

The table below lists competitors of Bloomage Biotechnology Corp Ltd ranked by their total liabilities.

Company Country Total Liabilities
Bird Construction Inc.
TO:BDT
Canada CA$1.48 Billion
Chongqing Zaisheng Tech Corp
SHG:603601
China CN¥861.86 Million
Olin Corporation
NYSE:OLN
USA $5.40 Billion
Sunway Construction Group Bhd
KLSE:5263
Malaysia RM3.68 Billion
Chicony Electronics Co Ltd
TW:2385
Taiwan NT$48.71 Billion
AstraZeneca PLC
LSE:AZN
UK GBX66.63 Billion
Fuchs Petrolub SE
XETRA:FPE
Germany €827.00 Million
IGB Real Estate Investment Trust
KLSE:5227
Malaysia RM1.47 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Bloomage Biotechnology Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Bloomage Biotechnology Corp Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.36 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bloomage Biotechnology Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bloomage Biotechnology Corp Ltd (2012–2025)

The table below shows the annual total liabilities of Bloomage Biotechnology Corp Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥1.58 Billion
≈ $230.82 Million
-13.19%
2024-12-31 CN¥1.82 Billion
≈ $265.87 Million
+22.22%
2023-12-31 CN¥1.49 Billion
≈ $217.53 Million
-25.63%
2022-12-31 CN¥2.00 Billion
≈ $292.48 Million
+10.96%
2021-12-31 CN¥1.80 Billion
≈ $263.58 Million
+189.28%
2020-12-31 CN¥622.68 Million
≈ $91.12 Million
+47.52%
2019-12-31 CN¥422.11 Million
≈ $61.77 Million
+19.39%
2018-12-31 CN¥353.56 Million
≈ $51.74 Million
+44.10%
2017-12-31 CN¥245.35 Million
≈ $35.90 Million
-42.07%
2016-12-31 CN¥423.53 Million
≈ $61.98 Million
-57.95%
2015-12-31 CN¥1.01 Billion
≈ $147.39 Million
+373.01%
2014-12-31 CN¥212.94 Million
≈ $31.16 Million
+4.40%
2013-12-31 CN¥203.96 Million
≈ $29.85 Million
+109.65%
2012-12-31 CN¥97.29 Million
≈ $14.24 Million
--

About Bloomage Biotechnology Corp Ltd

SHG:688363 China Specialty Chemicals
Market Cap
$2.50 Billion
CN¥17.08 Billion CNY
Market Cap Rank
#5607 Global
#1114 in China
Share Price
CN¥35.45
Change (1 day)
-1.25%
52-Week Range
CN¥33.47 - CN¥60.00
All Time High
CN¥303.37
About

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature nam… Read more